<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04956367</url>
  </required_header>
  <id_info>
    <org_study_id>2019-054</org_study_id>
    <nct_id>NCT04956367</nct_id>
  </id_info>
  <brief_title>Efficacy of Fractional Carbon Dioxide Laser Combined With Platelet-rich Plasma</brief_title>
  <official_title>Efficacy of Ablative Fractional Carbon Dioxide Laser Combined With Autologous Platelet-rich Plasma Versus Ablative Fractional Carbon Dioxide Laser and Placebo in the Treatment of Striae Gravidarum: a Randomized Clinical Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Jose R. Reyes Memorial Medical Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Jose R. Reyes Memorial Medical Center</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
    <is_us_export>Yes</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study determined the efficacy of ablative fractional carbon dioxide laser combined with&#xD;
      autologous platelet-rich plasma versus ablative fractional carbon dioxide laser with placebo&#xD;
      in the treatment of striae gravidarum of postpartum Filipino women.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">July 1, 2019</start_date>
  <completion_date type="Actual">November 30, 2019</completion_date>
  <primary_completion_date type="Actual">October 31, 2019</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Outcomes Assessor)</masking>
    <masking_description>Used a computer-generated software to randomize the area to be treated.</masking_description>
  </study_design_info>
  <primary_outcome>
    <measure>Clinical improvement</measure>
    <time_frame>16 weeks</time_frame>
    <description>Change in appearance based from clinical photos done in baseline, week 6, week 10, week 14 and week 16 . This will be assessed by quartile grading scale (poor, &lt;25% improvement; fair, 25-50% improvement; good, 51-75% improvement; and excellent, &gt;75% improvement)</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Patient satisfaction rate</measure>
    <time_frame>16 weeks</time_frame>
    <description>Self-reported by the patient using a quartile grading system with the following grades: 0 as poor; 1 as fair; 2 as satisfied; or 3 as very satisfied. The rating will be done at weeks 6, 10, 14 and 16.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">16</enrollment>
  <condition>Striae Gravidarum</condition>
  <arm_group>
    <arm_group_label>CO2 laser with PRP</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>After anesthetizing the area and undergo one pass of ablative fractional CO2 laser (Smaxel, iDS, Korea) using the following settings: energy = 50 mJ; pulse duration = 2 ms; and density level = 15, PRP will be injected through nappage technique at 1 cm intervals for three treatment sessions at four-week intervals.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>CO2 laser with placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>After anesthetizing the area and undergo one pass of ablative fractional CO2 laser (Smaxel, iDS, Korea) using the following settings: energy = 50 mJ; pulse duration = 2 ms; and density level = 15, pNSS will be injected through nappage technique at 1 cm intervals for three treatment sessions at four-week intervals.</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Ablative fractional carbon dioxide laser combined with autologous platelet-rich plasma</intervention_name>
    <description>Carbon dioxide laser (Smaxel.878.4810) was FDA-approved device used in dermatology practice. PRP was described as having growth factors to be used to promote healing.</description>
    <arm_group_label>CO2 laser with PRP</arm_group_label>
    <arm_group_label>CO2 laser with placebo</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>CO2 laser with PRP</intervention_name>
    <description>CO2 laser with PRP</description>
    <arm_group_label>CO2 laser with PRP</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>CO2 laser with placebo</intervention_name>
    <description>CO2 laser with placebo</description>
    <arm_group_label>CO2 laser with placebo</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Postpartum patients with ages 18 to 45 years&#xD;
&#xD;
          -  Fitzpatrick skin type III-V&#xD;
&#xD;
          -  having bilateral symmetrical SG of red, white or a combination of both types.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  pregnancy&#xD;
&#xD;
          -  breastfeeding&#xD;
&#xD;
          -  heavy consumption of alcoholic beverages&#xD;
&#xD;
          -  dermatological conditions such as psoriasis, systemic lupus erythematosus and atopic&#xD;
             dermatitis&#xD;
&#xD;
          -  uncontrolled hypertension, diabetes mellitus, heart disease, acute and chronic&#xD;
             liver/kidney impairment/disease;&#xD;
&#xD;
          -  elevated liver function tests (SGPT, SGOT), and serum creatinine;&#xD;
&#xD;
          -  intake of any medications that may influence the outcome of the study;&#xD;
&#xD;
          -  intake of any vitamins/minerals or any supplements in the past 6 months; and&#xD;
&#xD;
          -  application of any topical agents (e.g., whitening, anti-aging) in the past 6 months&#xD;
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>45 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Ivan Arni C Preclaro, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Jose R. Reyes Memorial Medical Center</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Jose R Reyes Memorial Medical Center</name>
      <address>
        <city>Manila</city>
        <state>NCR</state>
        <zip>1014</zip>
        <country>Philippines</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Philippines</country>
  </location_countries>
  <results_reference>
    <citation>Faghihi G, Keyvan S, Asilian A, Nouraei S, Behfar S, Nilforoushzadeh MA. Efficacy of autologous platelet-rich plasma combined with fractional ablative carbon dioxide resurfacing laser in treatment of facial atrophic acne scars: A split-face randomized clinical trial. Indian J Dermatol Venereol Leprol. 2016 Mar-Apr;82(2):162-8. doi: 10.4103/0378-6323.174378.</citation>
    <PMID>26924405</PMID>
  </results_reference>
  <verification_date>June 2021</verification_date>
  <study_first_submitted>June 22, 2021</study_first_submitted>
  <study_first_submitted_qc>July 8, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">July 9, 2021</study_first_posted>
  <last_update_submitted>July 8, 2021</last_update_submitted>
  <last_update_submitted_qc>July 8, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">July 9, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Jose R. Reyes Memorial Medical Center</investigator_affiliation>
    <investigator_full_name>Ivan Arni Preclaro</investigator_full_name>
    <investigator_title>Efficacy of ablative fractional carbon dioxide laser combined with autologous platelet-rich plasma versus ablative fractional carbon dioxide laser and placebo in the treatment of striae gravidarum: a randomized clinical trial</investigator_title>
  </responsible_party>
  <keyword>Striae Gravidarum</keyword>
  <keyword>carbon dioxide laser</keyword>
  <keyword>platelet-rich plasma</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Striae Distensae</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

